BioConsortia showcases breakthrough microbial products

BioConsortia’s innovative microbial products and technical capabilities were on full display August 30, 2022, at its Davis, California, headquarters in an investor-focused Technology Showcase event. BioConsortia demonstrated rapid advancements in microbial product and pipeline developments for reducing nitrogen fertilizers, controlling soil pests and plant diseases for larger and better-quality crop yields, as well as protecting crops post-harvest to avoid food waste, while minimizing environmental impact and protecting our planet.

Commercial advances

“Today we highlight the breadth of innovations developed to replace crop inputs with superior microbe-based solutions for agriculture,” said Marcus Meadows-Smith, CEO of BioConsortia, Inc. “The recent progress of our pipeline – including some exciting technology breakthroughs – means we are ready to advance multiple major products into the commercialization phase with marketing partners.”

The Technology Showcase event highlighted products moving into partner trials, commercialization phase and new pipeline projects, including:

• GARNET biofungicide in an optimized post-harvest formulation: GARNET, already proven as a foliar and soil fungicide, will also be made available as a 50 times concentrated formulation to protect both conventional and organic fruits and vegetables from a wide variety of post-harvest diseases that today limit shelf-life.
• Additions to the bionematicide pipeline and NO-NEM: BioConsortia added three new active ingredient leads to the nematicide pipeline and advanced NO-NEM, the company’s first nematicide, to full development phase.
• Novel genetic components for nitrogen-fixation: The company announced discovery of novel genetic components driving nitrogen-fixation, utilizing their GenePro platform, enabling BioConsortia’s scientists to design proprietary microbial strains that will fix nitrogen when other N-fixing strains will not.
• Bactericide and insecticides: Project leaders highlighted early technological success in projects aiming to deliver effective microbial metabolites for control of bacteria, and critically important coleopteran and lepidopteran insect pests.

“BioConsortia’s pipeline progress highlights the strengths of the company’s R&D platform – unique in the industry in terms of discovery of plant-affiliated microbes and their optimization as solutions for agriculture,” said Hong Zhu, senior vice president of research and development at BioConsortia.

Accelerating partnering activities

BioConsortia’s Technology Showcase included a session on the company’s plans to accelerate partnering activities. “BioConsortia is fundamentally a discovery and optimization company, designing microbial products to solve the challenges we must meet in order to feed a hungry world,” said CEO, Meadows-Smith. “Many projects are maturing rapidly and will soon enter the market. We look forward to working with commercial partners to deliver these powerful innovations to the market.”

Marcus Meadows-Smith, CEO, presenting at the BioConsortia Technology Showcase. Photo: BioConsortia